Global Hereditary Genetic Testing Market
Medical Equipment

Hereditary Genetic Testing Market Outlook 2026–2030: Key Business Drivers and Trends

Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

What was the valuation of the Hereditary Genetic Testing Market in 2026, and what figure is it projected to hit by 2030?

The hereditary genetic testing market size has seen swift expansion in recent years. This market is expected to grow from $23.88 billion in 2025 to $26.56 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.2%. Throughout the past, this growth was primarily due to an increasing prevalence of hereditary disorders, greater clinical adoption of molecular diagnostics, the expansion of diagnostic laboratories, heightened awareness of genetic diseases, and the availability of fundamental genetic testing technologies.

The hereditary genetic testing market is poised for rapid expansion in the coming years. It is projected to reach $40.12 billion by 2030, expanding at a compound annual growth rate (CAGR) of 10.9%. This anticipated growth is driven by several factors, including progress in next-generation sequencing technologies, an escalating need for personalized medicine, the broadening scope of pharmacogenomic applications, increased healthcare investment in preventive care, and greater incorporation of genetic counseling services. Key trends during this forecast period encompass a greater uptake of preventive and predictive genetic testing, a heightened call for early cancer risk assessment, the proliferation of direct-to-consumer genetic testing offerings, an increase in prenatal and newborn genetic screening, and enhanced understanding of inherited cardiovascular and rare diseases.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20559&type=smp

Which Drivers Are Affecting Market Participation In The Hereditary Genetic Testing Market?

The rising incidence of cancer is anticipated to drive expansion in the hereditary genetic testing market moving forward. Cancer describes a group of illnesses characterized by uncontrolled cell multiplication that can infiltrate or spread to other bodily regions. The growing occurrence of cancer stems from elements such as an aging demographic, shifts in lifestyle, environmental contaminants, inherited predispositions, and enhanced diagnostic approaches. Hereditary genetic testing aids in preventing cancer by detecting genetic mutations linked to heightened risk, thereby facilitating early monitoring and precise prevention methods. For instance, in August 2024, the Macmillan Cancer Support, a UK-based organization, stated that over 3 million individuals in the UK were living with cancer in 2024, with this number forecast to climb to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Consequently, the escalating prevalence of cancer is fueling the growth of the hereditary genetic testing market.

What Segment Classifications Make Up The Hereditary Genetic Testing Market?

The hereditary genetic testing market covered in this report is segmented –

1) By Type: Predictive And Presymptomatic Testing, Carrier Testing, Prenatal And Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, Other Types

2) By Technology: Cytogenetic Testing, Biochemical Testing, Molecular Testing

3) By Clinical Application: Cancer Genetic Testing, Cardiovascular Genetic Testing, Neurological Genetic Testing, Rare Diseases Genetic Testing

4) By End User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Direct To Consumer (DTC) Genetic Testing Companies

Subsegments:

1) By Predictive And Presymptomatic Testing: Genetic Testing For Disease Risk Prediction, Testing For Inherited Cancer Risks, Cardiovascular Disease Risk Testing, Neurodegenerative Disease Risk Testing

2) By Carrier Testing: Testing For Inherited Genetic Disorders, Genetic Screening For Autosomal Recessive Diseases, Testing For Carrier Status Of Inherited Conditions

3) By Prenatal and Newborn Testing: Non-Invasive Prenatal Testing (NIPT), Amniocentesis and Chorionic Villus Sampling (CVS), Newborn Screening For Genetic Disorders, Preconception Genetic Screening

4) By Diagnostic Testing: Genetic Testing For Confirming Suspected Genetic Disorders, Testing For Inherited Syndromes And Congenital Diseases, Diagnostic Testing For Cancer And Tumor Profiling

5) By Pharmacogenomic Testing: Genetic Testing For Drug Response And Efficacy, Testing For Drug Sensitivities And Side Effects, Personalized Medicine And Treatment Optimization

6) By Other Types: Genetic Testing For Wellness And Lifestyle, Genetic Testing For Ancestry And Genealogy, Research-Oriented Genetic Testing

What Industry Trends Are Transforming The Hereditary Genetic Testing Market?

Leading companies within the hereditary genetic testing market are dedicated to developing advanced genomic solutions, such as multi-cancer multigene panels, to improve early detection and personalized treatment options. These multi-cancer multigene panels are diagnostic tests designed to analyze multiple genes concurrently to identify genetic mutations linked to various cancer types, thereby assisting in early diagnosis and individualized therapy. For instance, in February 2024, Exact Sciences Corporation, a US-based provider of cancer screening and diagnostic tests, introduced the Riskguard hereditary cancer test. The Riskguard test generates a personalized report on gene-specific and familial cancer risks for 10 common cancers using a simple blood or saliva sample. It assists in comprehending cancer risk, informing screening and treatment plans, and assessing family risks. Additionally, it aids in tailoring treatment for patients already diagnosed with cancer and enhances risk stratification for those with a family history of cancer by identifying actionable gene variants.

Which Major Industry Participants Are Leading The Hereditary Genetic Testing Market Growth?

Major companies operating in the hereditary genetic testing market are F. Hoffmann‑La Roche Ltd., Abbott Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Hologic Inc., Exact Sciences Corporation, Fulgent Genetics Inc., BioReference Laboratories Inc., BGI Group, Invitae Corporation, Color Health Inc., MedGenome Inc., Devyser AB, Mapmygenome India Ltd., Igenomix S.L.P., Myriad Genetics Inc., Natera Inc., Ambry Genetics Corporation, GeneDx LLC, Centogene N.V., CooperSurgical Inc., Sema4

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/hereditary-genetic-testing-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Hereditary Genetic Testing Market?

North America was the largest region in the hereditary genetic testing market in 2025 and it is expected to be the fastest-growing region in the forecast period. The regions covered in the hereditary genetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Hereditary Genetic Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20559&type=smp

Browse Through More Reports Similar to the Global Hereditary Genetic Testing Market 2026, By The Business Research Company

Genetically Modified Fruits Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetically-modified-fruits-global-market-report

Optogenetics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/optogenetics-global-market-report

Genetically Modified Animal Products Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetically-modified-animal-products-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company